IR&MEDIA

NEWS

Dr. Chan-Ho Cho of Cheongdam Cell Clinic Demonstrates REV-MED’s NovaStem System Live, Sharing Clinical Expertise in Stem Cell Therapy

관리자
9 Jun 2026
Views 86

Dr. Chan-Ho Cho, Chief Director of Cheongdam Cell Clinic and a recognized expert in regenerative medicine, recently shared practical stem cell treatment techniques that can be directly applied in clinical settings during a specialized educational program for healthcare professionals.

The event, hosted by REV-MED in collaboration with the Korean Society of Aesthetic Functional Medicine, was held as part of a Stem Cell Academy program focused on hands-on clinical education. Designed around live demonstrations that replicated real treatment environments, the program provided participants with practical insights into regenerative medicine procedures and highlighted REV-MED’s technologies as core clinical solutions.

0219a2ef8e1ac.png

During the event, Dr. Cho led the “BMAC (Bone Marrow Aspirate Concentrate) Harvesting Hands-on Session,” where he demonstrated the complete workflow of processing highly concentrated bone marrow-derived cellular components using the NovaStem BMAC system. He also introduced injection techniques utilizing the DuoSafe Dual-Filter System, explaining important considerations for clinical implementation and procedural consistency.

Another featured speaker, Dr. Hyung-Moon Kim of Maylin Clinic Apgujeong, presented a session on scalp injection techniques utilizing bone marrow concentrate. The lecture focused on the application of concentrated cellular components and growth factors processed through REV-MED’s platform for regenerative and hair restoration procedures.

990a2ab8fb956.png

Commenting on the event, Dr. Cho stated:


“This academy was not simply a product introduction, but an opportunity to share clinically validated regenerative medicine techniques and standardized treatment processes from a practitioner’s perspective. Conducting live demonstrations in collaboration with a respected medical society demonstrates how these solutions are becoming recognized as practical and reliable options in clinical practice.”


He added:


“We will continue expanding academic exchange and clinical education programs to further enhance the safety, reproducibility, and real-world clinical value of regenerative medicine treatments.”


Dr. Cho currently serves as Vice President of the Korean Society of Stem Cell Therapy and has completed advanced studies in anti-aging medicine at Brigham and Women’s Hospital, Harvard Medical School. Cheongdam Cell Clinic was recently recognized in the 2025 Korea Medical Healthcare Awards, receiving the award in the Anti-Aging Stem Cell Therapy category and achieving its seventh consecutive year of recognition.

Source: Sports World

0 0